IMGN - ImmunoGen

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

IMGN - ImmunoGen

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ
#5622()/7561

Tue 14'th Aug 2018

PERIOD 2018-05-15 - 2018-08-14
CHANGE 0.88%
PRICE $9.22
VOLUME
Sell
TREND
Sell

MV LONG
Sell

MV SHORT
Buy

PIVOT
Buy

MACD
Sell

Request Prediction
0.00%
Predict

ImmunoGen Stock Analysis

Technical stock analysis for Tue 14'th Aug 2018

Sell candidate since 2018-07-27 Loss -5.87%
Shorts 6.66% ( 2018-07-31 )
Cash 462.0 mill
Loans n/a
Beta 1.93
ROA -53.35

ImmunoGen gained 0.88% in the last trading day, rising from $9.14 to $9.22 , and has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has risen in 5 of the last 10 days , but is still down by -0.86% for this period. Volume fell in the last day by -1 187 779 shares, and in total, 959 849 shares bought and sold for approximately $8.85 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Trend

ImmunoGen lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.81% during the next 3 months and, with 90% probability hold a price between $7.27 and $9.77 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Wednesday August 08, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. ImmunoGen holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $9.90. On a fall, the stock will find some support from the short-term average at $8.97. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 37 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

ImmunoGen finds support from accumulated volume at $9.15.

Support: $9.15 Price: $9.22 Resistance: $10.34

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.28 between high and low, or 3.11%. For the last week, the stock has had a daily average volatility of 4.73%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

IMGN $9.22 $0.08(0.88%)
IMGN is up $0.08 today, but where's it headed in September?
Zacks Investment Research is releasing its prediction for IMGN based on the 1-3 month system that more than doubles the S&P 500.

Click here – the IMGN analysis is free »
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with
START FREE 5-DAY TRIAL